Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation

Relapse is the major cause of treatment failure after allogeneic hematopoietic cell transplantation (alloHCT) for acute leukemia and myelodysplastic syndrome (MDS). Wilms' tumor antigen (WT1) is overexpressed in the majority of acute leukemia and MDS patients and has been proposed as a universa...

Descripción completa

Detalles Bibliográficos
Autores principales: Israyelyan, Anna, Goldstein, Leanne, Tsai, Weimin, Aquino, Lia, Forman, Stephen J., Nakamura, Ryotaro, Diamond, Don J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286541/
https://www.ncbi.nlm.nih.gov/pubmed/25243629
http://dx.doi.org/10.1038/bmt.2014.209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286541/
https://www.ncbi.nlm.nih.gov/pubmed/25243629
http://dx.doi.org/10.1038/bmt.2014.209

Ejemplares similares